- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04072783
Neurodevelopmental Outcomes in Craniosynostosis Repair
Context: Craniosynostosis is a common craniofacial abnormality which can be associated with various clinical syndromes. Though it has been established that children with craniosynostosis score lower on certain developmental tests, the effect of craniosynostosis and cranioplasty surgery on the neural circuitry and brain development is less well known or understood.
Objectives: The purpose of this study is to describe the effect of cranial vault remodeling in children with craniosynostosis on white matter tracts with tractography and Diffusion tensor imaging (DTI), functional MRI, and neurodevelopmental tests, before and after surgery as compared to age-matched controls.
Study Design: This will be a prospective study of patients diagnosed with craniosynostosis and who are going to have open or endoscopic cranial vault remodeling (CVR).
Study Measures: The study will measure MRI sequences before and after surgery and at set time intervals to quantify the effect of white matter tract maturity. Parallel to this, neurodevelopmental tests will be administered at these same intervals.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Craniosynostosis, the premature ossification and fusion of one or more cranial sutures, is a common craniofacial abnormality occurring in 1 of 2,000 live births. 1 2 Craniosynostosis can lead to increased intra-cranial pressure in between 12-50% of those affected which may have delayed neuro developmental implications.
The crucial neurodevelopment occurs in the first years of life and is most rapidly progressing during the first year of life. Premature closure of the cranial sutures decrease the intracranial volume and space available for the rapidly developing brain. Cranial vault remodeling (CVR) is the current standard of care to mitigate any possible developmental delay secondary to craniosynostosis and also improve the head shape. CVR is a combined surgery between the neurosurgeon who takes off the cranial bone/bones, and the craniofacial surgeon who assists and reconstructs the cranium with absorbable plates and screws.
After surgery, although there is no doubt that there is an improvement in head shape, the craniofacial skeleton and the soft tissues, but there is less data, and virtually no functional imaging information available addressing the effect of CVR surgery on the growing brain.
The main objective of this project would be to begin to explore the relationship of CVR and it requisite effects on the growing brain with a cohort of patients who are set to undergo CVR, while performing a battery of neurodevelopmental and imaging studies pre- and post-operatively and compare with normative controls. This is one part of a three-center study collaborating with craniofacial units at Yale University and Wake Forest University in which similar, if not identical protocols will be carried out. We hope that analyses of these data will provide better insight into and greater definition of the effect of CVR and the secondarily available increase in intra-cranial volume on the growing brain in the clinical setting of craniosynostosis.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Suzanne Huetter, MSN
- Phone Number: 1 (501) 364-3761
- Email: SHuetter2@uams.edu
Study Contact Backup
- Name: Eylem Ocal, MD
- Phone Number: 501-364-4641
- Email: EOcal@uams.edu
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Recruiting
- University of Arkansas for Medical Sciences
-
Contact:
- Eylem Ocal, MD
- Phone Number: 501-364-4641
- Email: EOcal@uams.edu
-
Contact:
- Suzanne Huetter, MSN
- Phone Number: 501-364-3761
- Email: SHuetter2@uams.edu
-
Principal Investigator:
- Eylem Ocal, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Up to 500 children, for all subjects, age of initial study entry: one test group between 3-6 months old( endoscopic assisted) , and the other 6-24 months of age ( open CVR) ) once enrolled, children will be included until 4 years of age.
- Diagnosed with craniosynostosis, single or multiple suture
- Babies with craniosynostosis syndrome including but not limited to Pfieffers, Aperts, Crouzons,and Menkes.
- Approximately 60 age-matched controls (3 in each group) not diagnosed with craniosynostosis syndrome, stratified by age groups starting at 3 months, 5 months, 7 months, 9 month 11 months, 13 months, 15 months, 17 months, 19 months, then every 3 months, 22 months, 25 months, 28 months, 31 months, 34 months, 37 months,40 months,43 months,46 months,49 months.
Exclusion Criteria:
- Children not meeting the inclusion criteria
- Children with traumatic brain injury, brain cancer, or VP shunt that could affect development.
- Children who have already undergone CVR repair
- Developmentally Normal children who cannot undergo or cannot be still for an awake or asleep non-sedated MRI
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patients with craniosynostosis
Patients with craniosynostosis will undergo pre - and post-operative imaging studies.
The surgery will be performed for these patients as standard of care.
They will also be tested fro neurodevelopment.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of brain development via diagnostic imaging
Time Frame: From 2 months age to 4 years of age
|
Will establish pilot data to establish a normative curve of white-matter tract development in normal children under 4 years of age using (DTI).
Fractional anisotropy (FA) (a main DTI parameter sensitive to white matter integrity) maps will be created to achieve a normative "white matter change curve" with from infancy to pre-school age.
|
From 2 months age to 4 years of age
|
Assessment of the change in white matter tract organization after cranial vaut remodeling surgery (CVR)
Time Frame: From 2 months age to 4 years of age
|
Will quantify the change in white matter tract organization after cranial vault remodeling (CVR) surgery in patients with craniosynostosis by analyzing pre- and post-operative DTI data.
This experimental cohort will also be examined in comparison to age-matched controls, pooled with other centers and compared with published data sets of normal babies from the Baby Connectome Project. .
The imaging will be repeated at three intervals after surgery leading up to approximately 4 years of age.
|
From 2 months age to 4 years of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of neurodevelopmental test results in craniosynostosis patients
Time Frame: From 2 months of age to 4 years of age
|
Will assess neurodevelopmental test results in craniosynostosis patients and seek to correlate these findings with white matter tract changes
|
From 2 months of age to 4 years of age
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eylem Ocal, MD, University of Arkansas
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 217610
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Craniosynostoses
-
Nucleo de Plastica AvancadaCompletedChildren With CraniosynostosesBrazil
-
University Hospital, MontpellierRecruiting
-
Children's National Research InstituteActive, not recruiting
-
Mayo ClinicEnrolling by invitation
-
Boston Children's HospitalCompletedCraniosynostosisUnited States
-
Assistance Publique - Hôpitaux de ParisUniversité de Cergy PontoiseCompleted
-
Seattle Children's HospitalNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Paul StrickerChildren's Anesthesiology Associates, Ltd.; Thomas B. and Jeannette E. Laws...Completed
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Gary F. Rogers, MDEunice Kennedy Shriver National Institute of Child Health and Human Development...Withdrawn
Clinical Trials on MRI,DTI, functional MRI
-
University Hospital, GrenobleCompletedDisorder of ConsciousnessFrance
-
University Hospital MuensterUnknownClinically Isolated Syndrome, CNS Demyelinating | Multiple Sclerosis - Relapsing RemittingGermany
-
IHU StrasbourgCompletedInflammatory Bowel Disease | Neoplastic PathologyFrance
-
Memorial Sloan Kettering Cancer CenterCompleted
-
University Hospitals of North Midlands NHS TrustActive, not recruitingPelvic Floor DysfunctionUnited Kingdom
-
Brighton and Sussex University Hospitals NHS TrustCompletedLacrimal Duct Obstruction | Lacrimal StenosisUnited Kingdom
-
Medical University of ViennaCompletedBrachial Plexus Neuropathies | Traumatic Brachial Plexus Lesion | Bionic Hand ReconstructionAustria
-
Centre Hospitalier St AnneAssistance Publique - Hôpitaux de Paris; National Research Agency, France; CENIR... and other collaboratorsUnknown
-
University of Wisconsin, MadisonNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Enrolling by invitationMultiple Sclerosis | MSUnited States